Showing results (91-100 of 156) with videos related to

Sort By:
Pageof 16
Research and Practice in Thrombosis and Haemostasis|June 22, 2023
Patients' and health care providers' perspectives on quality of hemophilia care in the Netherlands: a questionnaire and interview studyMartijn R Brands, Lotte Haverman, Jelmer J Muis, et al.
Transfusion|August 2, 2022
Measurement of post-transfusion red blood cell survival kinetics in sickle cell disease and β-Thalassemia: A biotin label approachJorn J Gerritsma, Nieke van der Bolt, Robin van Bruggen, et al.
Blood|February 13, 2015
von Willebrand factor propeptide and the phenotypic classification of von Willebrand diseaseYvonne V Sanders, Dafna Groeneveld, Karina Meijer, et al.
Blood|December 21, 2023
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trialSteven W Pipe, Peter Collins, Christophe Dhalluin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 29, 2021
Social participation is reduced in type 3 Von Willebrand disease patients and in patients with a severe bleeding phenotypeEva K Kempers, Calvin B van Kwawegen, Joke de Meris, et al.
Thrombosis and Haemostasis|February 24, 2006
Tolerance to factor VIII in a transgenic mouse expressing human factor VIII cDNA carrying an Arg(593) to Cys substitutionWendy S Bril, Pauline M W van Helden, Christina Hausl, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 15, 2024
Patient-reported data on the severity of Von Willebrand diseaseCalvin B van Kwawegen, Karin Fijnvandraat, Marieke J H A Kruip, et al.
Blood Advances|March 8, 2021
Population pharmacokinetics of the von Willebrand factor-factor VIII interaction in patients with von Willebrand diseaseLaura H Bukkems, Jessica M Heijdra, Nico C B de Jager, et al.
Thrombosis and Haemostasis|April 17, 2015
Inhibitors in nonsevere haemophilia A: outcome and eradication strategiesAlice S van Velzen, Corien L Eckhardt, Daniel P Hart, et al.
Pageof 16